Ceres Pharma SA
37.0 FTECeres Pharma reported revenue of €35.3m for the 2025 financial year (non-consolidated annual accounts filed with the NBB on 06 Jul 2026), with 37 full-time equivalents.
The score of Ceres Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +2 % Total assets +114 % Headcount (avg FTE) -3 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ceres Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €35.3m | ||||
| Net result | −€14.4m | ||||
| Equity | −€1.55m | ||||
| Cash | 395,847 € | ||||
| EBITDA | €2.78m | ||||
| Total assets | €265.9m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 11 Aug 2022
Ceres Pharma's financial analysis
- Solvency-0.6%sector median: 36.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ceres Pharma
Ceres Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0641.953.324
- VAT number
- BE0641953324
- Peppol
- Registered · 0208:0641953324 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Oct 2015
- Registered office
- 9051 Ghent
- Size
- Small · 37.0 FTE
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Manufacture of other food products n.e.c. (NACE 10890)
Ceres Pharma (SA) has been based in Ghent since 2015, active in: manufacture of other food products n.e.c.. For 2025, it reports revenue of €35.3m, a net loss of €14.4m and equity of −€1.55m. With 37.0 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -0.6%, below the median of its sector (36.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Ceres Pharma
Companies in the same business, of comparable size and area, outside its group.
- Cooper Consumer Health BE Wholesale of pharmaceutical and medical goods Ghent · balance sheet €48.5m
- BePharBel Manufacturing Manufacture of basic pharmaceutical products Courcelles · balance sheet €27.4m
- Thea Pharma Wholesale of pharmaceutical and medical goods Ghent · balance sheet €16.7m
- Departement Central de Fractionnement Manufacture of pharmaceutical preparations Brussels · balance sheet €19.7m
- Jubilant Life Sciences Wholesale of chemical products Merelbeke-Melle · balance sheet €24.4m
- UCB Pharma Manufacture of pharmaceutical preparations Anderlecht · balance sheet €20.7bn
- MEDI-MARKET Parapharmacies Retail sale of pharmaceutical products Evere · balance sheet €171.3m
- Novartis Pharma Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €168.8m
Frequently asked questions about Ceres Pharma
What is the revenue of Ceres Pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of Ceres Pharma amounts to 35,316,546 €.
What is the VAT number of Ceres Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0641953324 for Ceres Pharma, if the company is VAT-registered. Its company number (CBE) is 0641.953.324.
Where is the registered office of Ceres Pharma?
According to the CBE register, the registered office of Ceres Pharma is in 9051 Ghent.
What is the equity of Ceres Pharma?
At the close of the 2025 financial year, the equity of Ceres Pharma amounts to -1,550,308 €, a solvency of -0.6% of total assets.
How many people work at Ceres Pharma?
37.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Ceres Pharma?
The register lists 4 active mandates at Ceres Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ceres Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →